Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RETK666N Germline Pathogenic Variant

By sjmartinez • February 18, 2025

Yip AT, Kim TH, Peluso EM, Jacobsen SE, Yeh MW, Lechner MG. Medullary Thyroid Carcinoma and Clinical Outcomes in Heterozygous Carriers of the RET K666N Germline Pathogenic Variant. JCEM Case Rep. 2025 Feb 17;3(3):luaf002. doi: 10.1210/jcemcr/luaf002. PMID: 39963300; PMCID: PMC11831074.

Tags: Endocrinology, germline, medullary thyroid carcinoma, MEN2, pathogenic variant, Publications, RET K666N

“It’s Just a Matter of Doing It”: Women Veterans’ Experiences with Changing Behavior for Cardiovascular Risk Reduction

Clair K, Fletcher EH, Oishi A, Schweizer CA, Jackson L, Chanfreau C, Finley EP, Hamilton A, Moin T, Farmer MM, Bean-Mayberry B. "It's Just a[...]

Impact of Medicaid Continuous Glucose Monitor Expansion on Uptake, Glycemic Outcomes, and Engagement Among Adults With Type 2 Diabetes in a Federally Qualified Health Center

Solorzano W, Scarlett LD, Perini Villanueva G, Santiago Mangual K, Santana C, Escobar B, Rubio A, Jackson NJ, Tavares M, Borrell J, Brumley B, Moin[...]

Generalizable, high-throughput image analysis of subcellular structures using dispersion indices

Martin A, Zhang S, Williamson A, Tingley B, Pickus M, Zurakowski D, Nia HT, Shirihai O, Han X, Grinstaff MW. Generalizable, high-throughput image analysis of[...]